A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 4, 2004

Primary Completion Date

August 17, 2004

Study Completion Date

November 30, 2004

Conditions
Epilepsy
Interventions
DRUG

iv SPM 927 and oral placebo tablet

60-minute infusion iv SPM 927 and oral placebo tablet

DRUG

oral SPM 927 tablet and iv placebo

60-minute infusion placebo and oral SPM 927 tablet

DRUG

iv SPM 927 and oral placebo tablet

30-minute infusion iv SPM 927 and oral placebo tablet

DRUG

oral SPM 927 tablet and iv placebo

30-minute infusion placebo and oral SPM 927 tablet

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00800215 - A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 | Biotech Hunter | Biotech Hunter